How long is Lupron for breast cancer? It is usually taken for at least 5 years. Treatment longer than 5 years might be offered to women whose cancers have a higher chance of coming back.
Is Lupron FDA approved for breast cancer? Remarks. December 2016 Update: Lupron as ovarian suppressor in pre-menopausal breast cancer has been approved by the FDA per NCI. Beginning with cases diagnosed 1/1/2017 forward, code as hormone therapy. Lupron is a gonadotropin-releasing hormone analogue.
What is the success rate of hormone therapy for breast cancer? The study found that patients with 5 years of tamoxifen treatment showed better disease free survival than patients with 10 years of treatment (82% vs 78%, P = . 03), and no statistically significant differences in survival rate were found between these 2 groups (94% vs 91%, P = . 07).
What are the long term side effects of Lupron? Women have reported to the FDA hundreds of cases of insomnia, depression, joint pain, and more than 100 cases of blurred vision. About 900 reports cite side effects that children below age 13 have suffered, mostly within months of taking Lupron.